巨星醫療控股(02393.HK)訂立新重組支持協議及票據新重組計劃
巨星醫療控股(02393.HK)公佈,自公佈原重組支持協議起,公司及其顧問與票據持有人進行建設性對話,就債務重組達成協定。公司公佈新重組支持協議及有關票據的建議新重組計劃,新重組支持協議及建議重組已獲得持有票據未償還本金總額45%以上的若幹票據持有人支持。相關票據持有人已於今日(6日)作爲初步同意債權人訂立新重組支持協議。
公司表示,誠邀其所有票據持有人,包括已簽署原重組支持協議的債權人在同意費期限前簽署新重組支持協議,以獲取現金同意費。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.